ZHE JIANG DAYANG BIOTECH GROUP CO., LTD.

Zhe Jiang Dayang Biotech Group Co., Ltd.

003017

CNE100004736

Commodity Chemicals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 25/06/2024 BST			5-day change	1st Jan Change
16.38 ^CNY	+3.08%		-2.62%	-32.65%

05-22	Zhe Jiang Dayang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2023	CI
04-28	Zhejiang Xinzhichun Semiconductor Materials Co., Ltd. announced that it has received CNY 14.7143 million in funding from Zhe Jiang Dayang Biotech Group Co., Ltd.	CI

Tranche Update on Zhejiang Dayang Biology Technology Co.,Ltd.'s Equity Buyback Plan announced on November 26, 2021.

April 05, 2022 at 05:00 pm

From January 1, 2022 to March 31, 2022, the company has repurchased 587,900 shares, representing 0.98% for CNY 20.26 million. With this, the company has completed the repurchase of 587,900 shares, representing 0.98% for CNY 20.26 million under the buyback announced on November 26, 2021.

Latest news about Zhe Jiang Dayang Biotech Group Co., Ltd.

Zhe Jiang Dayang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2023	05-21	CI
Zhejiang Xinzhichun Semiconductor Materials Co., Ltd. announced that it has received CNY 14.7143 million in funding from Zhe Jiang Dayang Biotech Group Co., Ltd.	04-27	CI
Zhe Jiang Dayang Biotech Group Co., Ltd. Proposes Final Cash Dividend for 2023	04-26	CI
Tranche Update on Zhe Jiang Dayang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	04-02	CI
Zhe Jiang Dayang Biotech Group Co., Ltd. announces an Equity Buyback for CNY 84 million worth of its shares.	02-05	CI
Zhe Jiang Dayang Biotech Group Co., Ltd. authorizes a Buyback Plan.	02-01	CI
Zhejiang Dayang Biotech Group Co., Ltd. Approves Interim Cash Dividend for the Year 2023, Payable on November 14, 2023	11-08	CI
Certain A Shares of Zhejiang Dayang Biology Technology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 27-OCT-2023.	26/10/23	CI
Zhejiang Dayang Biotech Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23/10/23	CI
Zhejiang Dayang Biotech Group Co., Ltd. Approves Interim Cash Dividend for the Year 2023	20/09/23	CI
Zhejiang Dayang Biotech Group Co., Ltd. Announces the Profit Distribution Proposal for the First Half of 2023	30/08/23	CI
Zhejiang Dayang Biotech Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Fujian Shunyue Technology Co., Ltd. announced that it expects to receive CNY 96.672753 million in funding from Zhe Jiang Dayang Biotech Group Co., Ltd.	27/08/23	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 29 June 2023	20/06/23	CI
Dayang Biotech Vice Chairman Dies of Illness	22/05/23	MT
Zhejiang Dayang Biology Technology Co.,Ltd. Approves Cash Dividend for the Year 2022	16/05/23	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Proposes Cash Profit Distribution for 2022	25/04/23	CI
Zhejiang Dayang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23/04/23	CI
Zhejiang Dayang Biotech Sells Idle Properties	27/12/22	MT
Zhejiang Dayang Biology Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	23/10/22	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	21/08/22	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 08, 2022	01/07/22	CI
Tranche Update on Zhejiang Dayang Biology Technology Co.,Ltd.'s Equity Buyback Plan announced on November 26, 2021.	16/06/22	CI
Zhejiang Dayang Biology Technology Co.,Ltd.'s Equity Buyback announced on November 26, 2021, has expired with 2,800,000 shares, representing 4.7% for CNY 88.09 million.	13/06/22	CI
Zhejiang Dayang Biology Technology Co.,Ltd. Approves Final Cash Dividend for the Year 2021	12/05/22	CI

Chart Zhe Jiang Dayang Biotech Group Co., Ltd.

Duration

Period

Chart Zhe Jiang Dayang Biotech Group Co., Ltd.

More charts

Company Profile

Zhejiang Dayang Biotech Group Co Ltd is a China-based company mainly engaged in the production and sales of chemical raw materials such as inorganic salts and veterinary raw materials. The Company's main products include potassium carbonate, potassium bicarbonate, amproline hydrochloride, 2-chloro-6-fluorobenzaldehyde, etc. Its products are used in food, pesticide, fertilizer, medicine and glass fields. The Company conducts its businesses within the Chinese market and to overseas markets.

Sector

Commodity Chemicals

Calendar

15/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Commodity Chemicals

	1st Jan change	Capi.
ZHE JIANG DAYANG BIOTECH GROUP CO., LTD.	-32.65%	181M
AIR LIQUIDE	+2.94%	102B
SABIC	-11.86%	58.85B
PT CHANDRA ASRI PACIFIC TBK	+72.86%	47.79B
WANHUA CHEMICAL GROUP CO., LTD.	+11.16%	36.9B
LYONDELLBASELL INDUSTRIES N.V.	+0.74%	31.19B
WESTLAKE CORPORATION	+4.74%	18.85B
NINGXIA BAOFENG ENERGY GROUP CO., LTD.	+14.69%	17.05B
HENGLI PETROCHEMICAL CO.,LTD.	+9.34%	13.95B
RONGSHENG PETROCHEMICAL CO., LTD.	-3.67%	13.14B